Legislators
Bills
Statements
Lobbying
Travel
Searching...- Lobbying
- Lobbying by Ovid Therapeutics
Lobbying Relationship
Bills mentioned
H.R.3: Elijah E. Cummings Lower Drug Costs Now Act
Sponsor: Frank Pallone (D-N.J.)
S.2543: Prescription Drug Pricing Reduction Act of 2019
Sponsor: Charles E. Grassley (R-Iowa)
H.R.4493: Federal Employee Short-Term Disability Insurance Act of 2019
Sponsor: Eleanor Holmes Norton (D-D.C.)
S.4010: Creating Hope Reauthorization Act
Sponsor: Bob Casey (D-Pa.)
H.R.4439: Creating Hope Reauthorization Act
Sponsor: G. K. Butterfield (D-N.C.)
H.R.5376: Inflation Reduction Act of 2022
Sponsor: John Yarmuth (D-Ky.)
S.2938: Bipartisan Safer Communities Act
Sponsor: Marco Rubio (R-Fla.)
H.R.7667: Food and Drug Amendments of 2022
Sponsor: Anna G. Eshoo (D-Calif.)
H.R.4436: Daniel Anderl Judicial Security and Privacy Act of 2021
Sponsor: Mikie Sherrill (D-N.J.)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
| Lobbyist | Covered positions? |
|---|---|
| Benjamin Mason | Communications Director, Rep. David Young January 2017 - June 2017 |
| Patroski Lawson | n/a |
| Katie Landes | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate